Sign Up to like & get recommendations! 0
Published in 2018 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2018.2428
Abstract: There is no consensus on optimal follow-up for completely resected gastroenteropancreatic neuroendocrine tumors. Published guidelines for follow-up are complex and emphasize closer surveillance in the first 3 years after resection. Neuroendocrine tumors have a different… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Cancer Medicine"
DOI: 10.1002/cam4.4031
Abstract: Owing to its rarity and heterogeneity, the biological behavior and optimal therapeutic management of mixed neuroendocrine‐non‐neuroendocrine neoplasm (MiNEN) have not been established. Herein, we aimed to evaluate the clinicopathological characteristics and metastatic patterns of MiNEN. read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Cancer Medicine"
DOI: 10.1002/cam4.4463
Abstract: We have limited information about neuroendocrine carcinoma (NEC) of the gallbladder. The purpose of this paper is to compare clinical and pathological features between different age groups and prognostic factors for gallbladder NEC and how… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.22078
Abstract: Gastroenteropancreatic neuroendocrine neoplasms (GEP‐NEN) are relatively rare tumors that arise from the diffuse neuroendocrine system, and the biggest advances in molecular biology have helped in understanding these biological diversity of tumors over the past decades.… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Clinical Journal of Gastroenterology"
DOI: 10.1007/s12328-021-01547-8
Abstract: A 70-year-old Japanese woman who was treated for interstitial pneumonia (IP) with steroid therapy developed cholecystitis. A serial computed-tomography (CT) imaging showed irregular thickness of the fundus wall of the gallbladder and two rapidly enlarged… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Endocrinology and metabolism clinics of North America"
DOI: 10.1016/j.ecl.2018.05.001
Abstract: High-grade gastroenteropancreatic neuroendocrine neoplasms are well-differentiated neuroendocrine tumors or poorly differentiated small/large cell neuroendocrine carcinoma. Distinguishing these entities relies on different genetic backgrounds and resulting different biology. The new classification creates several problems. Almost all… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "European journal of cancer"
DOI: 10.1016/j.ejca.2022.03.007
Abstract: BACKGROUND Neuroendocrine neoplasms (NENs) are rare tumours with variable clinical behaviour. Their natural history is ideally best approached in large, multicentre and multinational registries with long-term patients' follow-up. The European Neuroendocrine Tumour Society registry aims to… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Human pathology"
DOI: 10.1016/j.humpath.2019.03.007
Abstract: Some rhabdomyosarcomas and sarcomatoid carcinomas with heterologous rhabdomyosarcomatous elements resemble high-grade neuroendocrine carcinoma, creating a diagnostic difficulty. The purpose of this study was to characterize the overlap of adult genitourinary rhabdomyosarcomas, excluding those occurring at… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2019.1703677
Abstract: ABSTRACT Introduction: Neuroendocrine tumors of the pancreas (pNETs) represent only 1% to 2% of all pancreatic neoplasms. These tumors can be classified as functional or nonfunctional tumors; as sporadic or from a genetic origin; as… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Medicine"
DOI: 10.1097/md.0000000000014989
Abstract: Rationale: Metastatic neuroendocrine neoplasms (NENs) to the breast are very rare entities comprising only 1% to 2% of all metastatic breast tumors. In this article, we describe a case of a neuroendocrine ileal neoplasm metastatic… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000029616
Abstract: Rationale: Colorectal neuroendocrine cancer (CRNEC) accounts for < 1% of all colorectal cancers. It presents in advanced stages and carries a risk of poor survival. CRNEC may be diagnosed incidentally on imaging or routine endoscopy.… read more here.